{"id":"https://openalex.org/W2165770167","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2198","title":"Lomeguatrib, a Potent Inhibitor of O6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors","display_name":"Lomeguatrib, a Potent Inhibitor of O6-Alkylguanine-DNA-Alkyltransferase: Phase I Safety, Pharmacodynamic, and Pharmacokinetic Trial and Evaluation in Combination with Temozolomide in Patients with Advanced Solid Tumors","alternate_titles":[],"publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W2165770167","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2198","mag":"2165770167","pmid":"https://pubmed.ncbi.nlm.nih.gov/16533784"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-05-2198","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2198","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2198","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/12/5/1577/1922158/1577.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2165770167"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/12/5/1577/1922158/1577.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055792960","display_name":"Malcolm Ranson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Malcolm Ranson","raw_affiliation_strings":["1Department of Medical Oncology, University of Manchester;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, University of Manchester;","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark R. Middleton","raw_affiliation_strings":["1Department of Medical Oncology, University of Manchester;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, University of Manchester;","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083898918","display_name":"John A. Bridgewater","orcid":"https://orcid.org/0000-0001-9186-1604","observed_orcids":["https://orcid.org/0000-0001-9186-1604"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Bridgewater","raw_affiliation_strings":["4Department of Oncology, Royal Free and University College Medical School, University College;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Oncology, Royal Free and University College Medical School, University College;","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023781617","display_name":"Siow Ming Lee","orcid":"https://orcid.org/0000-0002-1741-6235","observed_orcids":["https://orcid.org/0000-0002-1741-6235"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siow Ming Lee","raw_affiliation_strings":["4Department of Oncology, Royal Free and University College Medical School, University College;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Oncology, Royal Free and University College Medical School, University College;","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103545954","display_name":"Martin J. Dawson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Dawson","raw_affiliation_strings":["2Cancer Research UK Clinical and Experimental Pharmacology Group and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cancer Research UK Clinical and Experimental Pharmacology Group and","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002399007","display_name":"Debra Jowle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Debra Jowle","raw_affiliation_strings":["1Department of Medical Oncology, University of Manchester;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, University of Manchester;","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075397179","display_name":"Gavin Halbert","orcid":"https://orcid.org/0000-0001-8553-3647","observed_orcids":["https://orcid.org/0000-0001-8553-3647"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gavin Halbert","raw_affiliation_strings":["6Cancer Research UK Formulation Unit, Strathclyde University, Glasgow, United Kingdom; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Cancer Research UK Formulation Unit, Strathclyde University, Glasgow, United Kingdom; and","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111985911","display_name":"Sue Waller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sue Waller","raw_affiliation_strings":["5Cancer Research UK Drug Development Office, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Cancer Research UK Drug Development Office, London, United Kingdom;","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Helen McGrath","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helen McGrath","raw_affiliation_strings":["5Cancer Research UK Drug Development Office, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Cancer Research UK Drug Development Office, London, United Kingdom;","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023959739","display_name":"Lindsey A. Gumbrell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lindsey Gumbrell","raw_affiliation_strings":["5Cancer Research UK Drug Development Office, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Cancer Research UK Drug Development Office, London, United Kingdom;","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014228181","display_name":"R. Stanley McElhinney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Stanley McElhinney","raw_affiliation_strings":["7Chemistry Department, Trinity College, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Chemistry Department, Trinity College, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111592878","display_name":"Dorothy J. Donnelly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dorothy Donnelly","raw_affiliation_strings":["7Chemistry Department, Trinity College, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Chemistry Department, Trinity College, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032445704","display_name":"T. Brian H. McMurry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Brian H. McMurry","raw_affiliation_strings":["7Chemistry Department, Trinity College, Dublin, Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Chemistry Department, Trinity College, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077801086","display_name":"Geoffrey P. Margison","orcid":"https://orcid.org/0009-0001-5471-918X","observed_orcids":["https://orcid.org/0009-0001-5471-918X"]},"institutions":[{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Geoffrey P. Margison","raw_affiliation_strings":["3Cancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, Manchester, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, Manchester, United Kingdom;","institution_ids":["https://openalex.org/I4210129527"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.3253,"has_fulltext":true,"cited_by_count":156,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95891279,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"12","issue":"5","first_page":"1577","last_page":"1584"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.41019999980926514,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.41019999980926514,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.28760001063346863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.10429999977350235,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9039999842643738},{"id":"https://openalex.org/keywords/o6-methylguanine-dna-methyltransferase","display_name":"O6-methylguanine-DNA methyltransferase","score":0.984000027179718},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.6290000081062317},{"id":"https://openalex.org/keywords/temozolomide-resistance","display_name":"temozolomide resistance","score":0.7979999780654907},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9020000100135803},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7900000214576721},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9700000286102295},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8109999895095825},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9570000171661377},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.3400000035762787},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8968871831893921},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.706838846206665},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6853506565093994},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5953438878059387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5450629591941833},{"id":"https://openalex.org/C2779527866","wikidata":"https://www.wikidata.org/wiki/Q21118735","display_name":"O-6-methylguanine-DNA methyltransferase","level":5,"score":0.473448246717453},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.38736552000045776},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35356903076171875},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34090226888656616},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2705587148666382},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.18941596150398254},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08887878060340881},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077204","descriptor_name":"Temozolomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000251","descriptor_name":"Adenosine Triphosphatases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003606","descriptor_name":"Dacarbazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019853","descriptor_name":"O(6)-Methylguanine-DNA Methyltransferase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019853","descriptor_name":"O(6)-Methylguanine-DNA Methyltransferase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1158/1078-0432.ccr-05-2198","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2198","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2198","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/12/5/1577/1922158/1577.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:16533784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16533784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/cea9c0eb-1651-449e-80ca-7ae0f8cce888","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/cea9c0eb-1651-449e-80ca-7ae0f8cce888","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:162950","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/162950/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research , 12 (5) pp. 1577-1584. (2006)","raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:39891","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/39891/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"CLINICAL CANCER RESEARCH , 12 (5) pp. 1577-1584. (2006)","raw_type":"Article"},{"id":"pmh:oai:strathprints.strath.ac.uk:10605","doi":null,"is_oa":false,"landing_page_url":"https://strathprints.strath.ac.uk/10605/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402226","display_name":"Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181647926","host_organization_name":"University of Strathclyde","host_organization_lineage":["https://openalex.org/I181647926"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-05-2198","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2198","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2198","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/12/5/1577/1922158/1577.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2165770167.pdf","grobid_xml":"https://content.openalex.org/works/W2165770167.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W75281861","https://openalex.org/W1597382206","https://openalex.org/W1600352032","https://openalex.org/W1669292210","https://openalex.org/W1806652950","https://openalex.org/W1833181362","https://openalex.org/W1961880800","https://openalex.org/W1988299559","https://openalex.org/W1990739350","https://openalex.org/W2028056960","https://openalex.org/W2033131256","https://openalex.org/W2041332808","https://openalex.org/W2052100484","https://openalex.org/W2069573820","https://openalex.org/W2071248985","https://openalex.org/W2077670941","https://openalex.org/W2081797247","https://openalex.org/W2095443177","https://openalex.org/W2103270230","https://openalex.org/W2107018012","https://openalex.org/W2114753552","https://openalex.org/W2138545604","https://openalex.org/W2140693914","https://openalex.org/W2141521501","https://openalex.org/W2166382251","https://openalex.org/W2167895705","https://openalex.org/W2170041042","https://openalex.org/W2416692478","https://openalex.org/W2434560817","https://openalex.org/W2468821301","https://openalex.org/W4235858387","https://openalex.org/W4244513882"],"related_works":["https://openalex.org/W2070851134","https://openalex.org/W633937366","https://openalex.org/W2048573295","https://openalex.org/W1980195588","https://openalex.org/W2071248985","https://openalex.org/W2052100484","https://openalex.org/W2145047381","https://openalex.org/W2587374118"],"abstract_inverted_index":{"PURPOSE:":[0],"A":[1],"major":[2],"mechanism":[3],"of":[4,18,30,42,64,86,92,112,125,145,159,183,190,205,208,216,247,256],"resistance":[5],"to":[6,24,37,44,66,71,104,110,116,199,249],"temozolomide":[7,43,93,191,211,264],"involves":[8],"the":[9,84,90,118,126,146,181,186,206],"DNA":[10],"repair":[11],"protein":[12],"O6-alkylguanine-DNA-alkyltransferase":[13],"(ATase).":[14],"The":[15,201,214],"main":[16],"aims":[17],"this":[19],"phase":[20],"I":[21],"trial":[22],"were":[23,135],"determine":[25],"an":[26,253],"ATase-depleting":[27],"dose":[28,41,62,91,121,148,189,202],"(ADD)":[29],"lomeguatrib,":[31],"a":[32,39,74,113,260],"potent":[33],"pseudosubstrate":[34],"inhibitor,":[35],"and":[36,77,122,171,210,232,258],"define":[38,117],"suitable":[40,265],"be":[45],"used":[46],"in":[47,51,79,94,98,151,192],"combination":[48,80,95,193,207,261],"with":[49,53,81,131,224,263],"lomeguatrib":[50,87,157,184,209,217,248,257],"patients":[52,130,223,234],"advanced":[54,132],"cancer.":[55],"EXPERIMENTAL":[56],"DESIGN:":[57],"Lomeguatrib":[58],"was":[59,88,96,149,194,212,219,230],"administered":[60],"at":[61,156,239],"levels":[63],"10":[65],"40":[67],"mg/m2":[68,106,196],"days":[69,108,197],"1":[70,109,198],"5,":[72],"as":[73],"single":[75],"agent,":[76],"also":[78],"temozolomide.":[82],"Once":[83],"ADD":[85,182,255],"identified,":[89],"increased,":[97],"successive":[99],"patient":[100],"cohorts,":[101],"from":[102],"50":[103],"175":[105],"on":[107],"5":[111],"28-day":[114],"cycle":[115],"maximal":[119,187],"tolerated":[120,188],"dose-limiting":[123],"toxicity":[124,204,215],"combination.":[127],"RESULTS:":[128],"Thirty-eight":[129],"solid":[133],"tumors":[134],"enrolled.":[136],"More":[137],"than":[138],"95%":[139],"ATase":[140,178],"depletion":[141],"within":[142],"4":[143],"hours":[144],"first":[147,245],"achieved":[150],"peripheral":[152],"blood":[153],"mononuclear":[154],"cells":[155],"doses":[158],">":[160,166,175],"or":[161,165,167,176],"=10":[162],"mg/m2/d":[163,169],"i.v.":[164],"=20":[168],"orally,":[170],"tumor":[172],"biopsies":[173],"showed":[174],"=92%":[177],"depletion.":[179],"At":[180],"i.v.,":[185],"150":[195],"5.":[200],"limiting":[203],"myelosuppression.":[213],"alone":[218],"minimal.":[220],"In":[221],"23":[222],"measurable":[225],"disease,":[226],"one":[227],"complete":[228],"response":[229],"seen":[231],"12":[233],"had":[235],"stable":[236],"disease":[237],"for":[238,266],"least":[240],"3":[241],"months.":[242],"CONCLUSION:":[243],"This":[244],"administration":[246],"man":[250],"successfully":[251],"established":[252],"oral":[254],"identified":[259],"regimen":[262],"future":[267],"clinical":[268],"evaluation.":[269]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2165770167","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
